According to NeuroMetrix, Quell is a wearable intensive nerve stimulation device that stimulates sensory nerves in the u…
Neuropathy
FDA Approves Janssen’s NUCYNTA ER for Diabetic Peripheral Neuropathy Pain
The U.S. FDA has approved the supplemental New Drug Application (sNDA), submitted by Janssen Pharmaceuticals, for NUCYNT…
Pfizer Drug Lyrica Fails in Phase 3 Study In Patients With Diabetic Peripheral Neuropathy
Pfizer Inc. has announced that a Phase 3 randomized withdrawal design study for Lyrica (pregabalin) in patients with ina…
Tranzyme Pharma, Developing a New Drug for Treatment of Diabetic Gastroparesis
Currently, there are no safe and effective drugs on the market for treating gastroparesis...…
Talking About Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathy (DPN) is nerve damage that affects the feet, legs, arms and hands. It's a potential comp…
Pfizer Stops Diabetic Nerve Pain Drug Trials at FDA Request
Pfizer Inc. announced, at the request of the U.S. Food and Drug Administration (FDA), the suspension of the chronic low …
